Medarex, Inc. (MEDX) Wrap Up:

We are a biopharmaceutical company focused on the discovery, development and commercialization of fully human antibody-based therapeutic product candidates. We believe that our UltiMAb® technology platform enables us to rapidly create and develop such products for a wide range of diseases, including cancer, inflammation, autoimmune disorders and other life-threatening and debilitating diseases. Medarex is committed to building value by developing a diverse pipeline of antibody products to address major unmet healthcare needs in the world. Currently, over 40 antibody product candidates generated from our UltiMAb® technology are in human clinical trials, or have had regulatory applications submitted for such trials(1).  ... More..."http://secfilings.nasdaq.com/edgar_conv_html%2f2008%2f02%2f27%2f0001047469-08-001844.html#FIS_BUSINESS"